All bacterial vaginosis articles
-
NewsResearchers develop new DNA test for personalized treatment of bacterial vaginosis
Researchers have developed a simple DNA PCR-based lab test — built on a more detailed genetic analysis of the main group of bacterial organisms that cause bacterial vaginosis — to help clinicians prescribe the right medicine for each patient.
-
FeaturesThe shifting landscape of the cervicovaginal microbiome in chlamydia infection
Bacterial vaginosis (BV) is a remarkably common condition among women of reproductive age, affecting as many as a third of all women at any given time. Yet it remains surprisingly elusive.
-
NewsChanges in microbiome predict risk for sexually transmitted disease
Researchers have found that bacterial vaginosis consists of two subtypes—one of which significantly increases the risk of developing chlamydia infections.
-
NewsUniversity awarded $1.5 million to study vaginal bacterial disorder linked to serious health risks
With a $1.5 million grant from the National Institutes of Health (NIH), researchers at the Case Western Reserve School of Medicine will study the dynamics of bacterial vaginosis in hopes of identifying a more effective approach.
-
NewsWomen’s health company Freya Biosciences announces key $10.4m strategic investment
Freya Biosciences, a transatlantic biotech company specializing in women’s health, has announced a major strategic investment which will be used to develop microbial immunotherapies for the treatment of bacterial vaginosis.
-
NewsResearcher targets BV, a common infection affecting women
A biomedical professor is targeting one of the most common – and dangerous – infections in women. With the help of a five-uear grant, she will study Bacterial Vaginosis (BV) and, ultimately, offer more effective personalized treatments.
-
NewsHuman cervix modeled in microfluidic organ chip helps target bacterial vaginosis
Engineered cervix with in vivo-like mucus production, hormone sensitivity, and associated microbiome creates novel testbed for bacterial vaginosis therapeutics and other treatments.
-
NewsStudy sheds light on bacteria associated with pre-term birth
Researchers have found that multiple species of Gardnerella, bacteria sometimes associated with bacterial vaginosis (BV) and pre-term birth, can coexist in the same vaginal microbiome.
-
NewsWomen need better treatments for bacterial vaginosis: call
Researchers at the University of Maryland School of Medicine are calling for robust studies for a treatment already used in Europe.
-
NewsResearchers call for regulation of direct-to-consumer microbiome tests
Scientists argue that direct-to-consumer (DTC) microbiome tests lack analytical and clinical validity and require more federal regulation to prevent consumer harm.
-
NewsScientists reveal what happens when the vaginal microbiome attacks
A new study examines why a common and seemingly benign condition of the vaginal microbiome - bacterial vaginosis - is linked to pregnancy loss, preterm birth and other health complications.
-
NewsStudy reveals bias in AI tools when diagnosing women’s health issue
Machine learning algorithms designed to diagnose a common infection that affects women showed a diagnostic bias among ethnic groups, researchers have found.
-
NewsMultiple species band together in polymicrobial biofilms to defeat bacterial vaginosis treatments
Scientists will have to rethink their approach to treating bacterial vaginosis due to the presence of a multi-species biofilm that complicates testing.
-
NewsGedea Biotech buoyed by results for antibiotic-free treatment for bacterial vaginosis
Women’s health company Gedea Biotech is moving towards approval for its antibiotic-free treatment for bacterial vaginosis following positive results from its NEFERTITI clinical study.